{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:47:30Z","timestamp":1776890850655,"version":"3.51.2"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2026.03.027","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:57:52Z","timestamp":1776887872000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re: Jurczok N, Dernbach G, Ebner B, et\u00a0al. Multiregional immune profiling reveals prognostic patterns in bladder cancer. Eur Urol Oncol. In press. http:\/\/dx.doi.org\/10.1016\/j.euo.2025.12.006"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3664-5547","authenticated-orcid":false,"given":"Kiyo","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyasu","family":"Takefuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.03.027_b0005","doi-asserted-by":"crossref","unstructured":"Jurczok N, Dernbach G, Ebner B, et\u00a0al. Multiregional immune profiling reveals prognostic patterns in bladder cancer. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2025.12.006.","DOI":"10.1016\/j.euo.2025.12.006"},{"key":"10.1016\/j.euo.2026.03.027_b0010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.euo.2026.03.027_b0015","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/1078-0432.CCR-24-0566","article-title":"Proportional hazards violations in Phase III cancer clinical trials: a potential source of trial misinterpretation","volume":"30","author":"Lin","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euo.2026.03.027_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.euo.2022.01.008","article-title":"Immune contexture and differentiation features predict outcome in bladder cancer","volume":"5","author":"Taber","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.027_b0025","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.euo.2024.03.015","article-title":"Prognostic significance of immune cell infiltration in muscle-invasive bladder cancer treated with definitive chemoradiation: a secondary analysis of RTOG 0524 and RTOG 0712","volume":"7","author":"Rana","year":"2024","journal-title":"Eur Urol Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T19:57:53Z","timestamp":1776887873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":5,"alternative-id":["S2588931126000957"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.027","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Jurczok N, Dernbach G, Ebner B, et\u00a0al. Multiregional immune profiling reveals prognostic patterns in bladder cancer. Eur Urol Oncol. In press. http:\/\/dx.doi.org\/10.1016\/j.euo.2025.12.006","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}